Welcome to our dedicated page for Lucy Scientific Discovery news (Ticker: LSDI), a resource for investors and traders seeking the latest updates and insights on Lucy Scientific Discovery stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Lucy Scientific Discovery's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Lucy Scientific Discovery's position in the market.
Lucy Scientific Discovery (NASDAQ: LSDI) has received a Nasdaq notification of non-compliance with Listing Rule 5250(c)(1). The company is delinquent in filing its Quarterly Report for Q1 2024, jeopardizing its listing status. A hearing is set for June 25, 2024, with a Nasdaq Hearings Panel regarding its compliance plan. The company aims to regain compliance with both the Stockholders’ Equity Rule and the Filings Rule but faces uncertainty regarding the panel's decision.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.